You are here
Tribunal upholds CQC decision to close drug treatment service
A decision by the Care Quality Commission to close a London clinic for people who needed support with substance misuse has been upheld by an independent tribunal at the Royal Courts of Justice.
People who used the clinic are now being offered support to find an alternative service.
Islington based AdAstra provides substitute medicines to more than 140 clients who were travelling to the clinic from a 50 mile radius. Around 60 of AdAstra’s clients are currently prescribed medication that exceeds current recommended levels and they will need careful support in the future.
CQC had serious concerns regarding the safety, effectiveness and leadership of the private drug treatment service - and proposed to cancel the provider’s registration - effectively forcing it to close. The provider appealed against the decision to a care standards tribunal.
Judge Melanie Lewis said:
“These matters present a risk to the health and welfare of service users. Cancellation of registration is an appropriate and proportionate sanction in all the circumstances of the case.”
Jane Ray, CQC’s Head of Hospital Inspections (Mental Health, Substance Misuse and Learning Disabilities), said:
“We had serious concerns as the clinic was not providing treatment in line with current guidance on best practice. Prescriptions were not being managed safely. Clients were not receiving appropriate support with their physical health needs and the clinic was not working in partnership with the clients GPs."
“We initially thought of the immediate closure of the clinic. Instead we decided to take a slower approach to allow alternative arrangements to be put into place for the clients. This gave the clinic time to make improvements and appeal against our decision. Unfortunately the provider did not make the necessary improvements which is why the tribunal upheld our decision.”
In February 2017, CQC undertook its latest inspection to monitor any progress the provider had made and to update the tribunal. That inspection report will be published shortly.
Islington commissioners have arranged for two local substance misuse providers to be available to speak to AdAstra clients on an individual basis and offer support to signpost them to alternative services.
CQC has asked AdAstra to contact all their 142 clients and ask if anyone does not want their details passed onto the two local substance misuse providers.
For further information please contact Ray Cooling, Regional Engagement Manager (London), on 020 7448 9136 or call the press office on 020 7448 9401 during office hours.
Journalists wishing to speak to the press office outside of office hours can find out how to contact the team here.
Please note: the press office is unable to advise members of the public on health or social care matters. For general enquiries, please call 03000 61 61 61.
- Last updated:
- 29 May 2017
Notes to editors
- Are they safe?
- Are they effective?
- Are they caring?
- Are they responsive to people’s needs?
- Are they well-led?